APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inactivated Polio and Rabies Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inactivated Polio and Rabies Vaccines Industry Growth and Trends Forecast to 2032

29 December 202590 pages

Choose your research edition.

Industry ResearchInactivated Polio and Rabies Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Inactivated Polio and Rabies Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Inactivated Polio and Rabies Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inactivated Polio and Rabies Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Inactivated Polio and Rabies Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Inactivated Polio and Rabies Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Kedrion Biopharma, Serum Institute of India, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inactivated Polio and Rabies Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inactivated Polio and Rabies Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inactivated Polio and Rabies Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inactivated Polio and Rabies Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inactivated Polio and Rabies Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inactivated Polio and Rabies Vaccines Market by Company

Bharat Biotech

BIO-MED

Kedrion Biopharma

Serum Institute of India

GlaxoSmithKline

Pfizer

Merck

Inactivated Polio and Rabies Vaccines Segment by Type

Inactivated Polio Vaccine

Inactivated Rabies Vaccine

Inactivated Polio and Rabies Vaccines Segment by Application

Pediatrics

Adults

Inactivated Polio and Rabies Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Polio and Rabies Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inactivated Polio and Rabies Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Polio and Rabies Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inactivated Polio and Rabies Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inactivated Polio and Rabies Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Polio Vaccine Table 2. Major Company of Inactivated Rabies Vaccine Table 3. Global Inactivated Polio and Rabies Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 5. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Inactivated Polio and Rabies Vaccines Price by Type (2021-2026) & (US$/Unit) Table 9. Global Inactivated Polio and Rabies Vaccines Sales by Type (2027-2032) & (K Units) Table 10. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Inactivated Polio and Rabies Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Inactivated Polio and Rabies Vaccines Price by Type (2027-2032) & (US$/Unit) Table 14. North America Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 15. North America Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 17. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 21. Latin America Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Inactivated Polio and Rabies Vaccines Industry Trends Table 25. Inactivated Polio and Rabies Vaccines Industry Drivers Table 26. Inactivated Polio and Rabies Vaccines Industry Opportunities and Challenges Table 27. Inactivated Polio and Rabies Vaccines Industry Restraints Table 28. Global Inactivated Polio and Rabies Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Inactivated Polio and Rabies Vaccines Sales by Company (2021-2026) & (K Units) Table 31. Global Inactivated Polio and Rabies Vaccines Sales Share by Company (2021-2026) Table 32. Global Inactivated Polio and Rabies Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Inactivated Polio and Rabies Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Inactivated Polio and Rabies Vaccines Major Company Production Sites and Headquarters Table 35. Global Inactivated Polio and Rabies Vaccines Company, Product Type & Application Table 36. Global Inactivated Polio and Rabies Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Inactivated Polio and Rabies Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Inactivated Polio and Rabies Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Inactivated Polio and Rabies Vaccines Sales by Region (2021-2026) & (K Units) Table 41. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Inactivated Polio and Rabies Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Inactivated Polio and Rabies Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Inactivated Polio and Rabies Vaccines Sales by Region (2027-2032) & (K Units) Table 46. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Inactivated Polio and Rabies Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Inactivated Polio and Rabies Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Inactivated Polio and Rabies Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 52. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Inactivated Polio and Rabies Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Inactivated Polio and Rabies Vaccines Sales by Application (2027-2032) & (K Units) Table 57. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Inactivated Polio and Rabies Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Inactivated Polio and Rabies Vaccines Price by Application (2027-2032) & (US$/Unit) Table 61. North America Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 62. North America Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 64. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 68. Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Bharat Biotech Company Information Table 72. Bharat Biotech Business Overview Table 73. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio Table 75. Bharat Biotech Recent Development Table 76. BIO-MED Company Information Table 77. BIO-MED Business Overview Table 78. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio Table 80. BIO-MED Recent Development Table 81. Kedrion Biopharma Company Information Table 82. Kedrion Biopharma Business Overview Table 83. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio Table 85. Kedrion Biopharma Recent Development Table 86. Serum Institute of India Company Information Table 87. Serum Institute of India Business Overview Table 88. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio Table 90. Serum Institute of India Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio Table 100. Pfizer Recent Development Table 101. Merck Company Information Table 102. Merck Business Overview Table 103. Merck Inactivated Polio and Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Merck Inactivated Polio and Rabies Vaccines Product Portfolio Table 105. Merck Recent Development Table 106. North America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 108. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2026) Table 109. North America Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Inactivated Polio and Rabies Vaccines Sales Market Share Forecast by Country (2027-2032) Table 111. North America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Inactivated Polio and Rabies Vaccines Market Share by Country (2021-2026) Table 114. North America Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Inactivated Polio and Rabies Vaccines Market Share Forecast by Country (2027-2032) Table 116. Europe Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 118. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2026) Table 119. Europe Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Inactivated Polio and Rabies Vaccines Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Inactivated Polio and Rabies Vaccines Market Share by Country (2021-2026) Table 124. Europe Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Inactivated Polio and Rabies Vaccines Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Share by Country (2021-2026) Table 134. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Share Forecast by Country (2027-2032) Table 136. Latin America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 138. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2026) Table 139. Latin America Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Inactivated Polio and Rabies Vaccines Market Share by Country (2021-2026) Table 144. Latin America Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Inactivated Polio and Rabies Vaccines Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Share by Country (2021-2026) Table 154. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Inactivated Polio and Rabies Vaccines Distributors List Table 159. Inactivated Polio and Rabies Vaccines Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Inactivated Polio and Rabies Vaccines Image Figure 2. Global Inactivated Polio and Rabies Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inactivated Polio and Rabies Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Inactivated Polio and Rabies Vaccines Sales (2021-2032) & (K Units) Figure 5. Inactivated Polio Vaccine Image Figure 6. Global Inactivated Polio Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inactivated Rabies Vaccine Image Figure 8. Global Inactivated Rabies Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Inactivated Polio and Rabies Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Inactivated Polio and Rabies Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Inactivated Polio and Rabies Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pediatrics Image Figure 24. Global Pediatrics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Inactivated Polio and Rabies Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Inactivated Polio and Rabies Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America Inactivated Polio and Rabies Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Inactivated Polio and Rabies Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Inactivated Polio and Rabies Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Inactivated Polio and Rabies Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Inactivated Polio and Rabies Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Inactivated Polio and Rabies Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Inactivated Polio and Rabies Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Inactivated Polio and Rabies Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Inactivated Polio and Rabies Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Inactivated Polio and Rabies Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Inactivated Polio and Rabies Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Inactivated Polio and Rabies Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Inactivated Polio and Rabies Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Polio Vaccine
  • Inactivated Rabies Vaccine
Applications
  • Pediatrics
  • Adults
Companies covered
  • Bharat Biotech
  • BIO-MED
  • Kedrion Biopharma
  • Serum Institute of India
  • GlaxoSmithKline
  • Pfizer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inactivated Polio and Rabies Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inactivated Polio and Rabies Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inactivated Polio and Rabies Vaccines Market by Type
  6. 1.3.1 Inactivated Polio Vaccine
  7. 1.3.2 Inactivated Rabies Vaccine
  8. 1.4 Global Inactivated Polio and Rabies Vaccines Market Size by Type
  9. 1.4.1 Global Inactivated Polio and Rabies Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Inactivated Polio and Rabies Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Inactivated Polio and Rabies Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inactivated Polio and Rabies Vaccines Industry Trends
  2. 2.2 Inactivated Polio and Rabies Vaccines Industry Drivers
  3. 2.3 Inactivated Polio and Rabies Vaccines Industry Opportunities and Challenges
  4. 2.4 Inactivated Polio and Rabies Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inactivated Polio and Rabies Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Inactivated Polio and Rabies Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Inactivated Polio and Rabies Vaccines Price (2021-2026)
  4. 3.4 Global Inactivated Polio and Rabies Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inactivated Polio and Rabies Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Inactivated Polio and Rabies Vaccines Company, Product Type & Application
  7. 3.7 Global Inactivated Polio and Rabies Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inactivated Polio and Rabies Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inactivated Polio and Rabies Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inactivated Polio and Rabies Vaccines Tier 1, Tier 2, and Tier 3
4 Inactivated Polio and Rabies Vaccines Regional Status and Outlook
  1. 4.1 Global Inactivated Polio and Rabies Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inactivated Polio and Rabies Vaccines Historic Market Size by Region
  3. 4.2.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inactivated Polio and Rabies Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inactivated Polio and Rabies Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inactivated Polio and Rabies Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inactivated Polio and Rabies Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inactivated Polio and Rabies Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inactivated Polio and Rabies Vaccines by Application
  1. 5.1 Inactivated Polio and Rabies Vaccines Market by Application
  2. 5.1.1 Pediatrics
  3. 5.1.2 Adults
  4. 5.2 Global Inactivated Polio and Rabies Vaccines Market Size by Application
  5. 5.2.1 Global Inactivated Polio and Rabies Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Inactivated Polio and Rabies Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Inactivated Polio and Rabies Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 BIO-MED
  8. 6.2.1 BIO-MED Company Information
  9. 6.2.2 BIO-MED Business Overview
  10. 6.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio
  12. 6.2.5 BIO-MED Recent Developments
  13. 6.3 Kedrion Biopharma
  14. 6.3.1 Kedrion Biopharma Company Information
  15. 6.3.2 Kedrion Biopharma Business Overview
  16. 6.3.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio
  18. 6.3.5 Kedrion Biopharma Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck Inactivated Polio and Rabies Vaccines Product Portfolio
  42. 6.7.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Inactivated Polio and Rabies Vaccines Sales by Country
  2. 7.1.1 North America Inactivated Polio and Rabies Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inactivated Polio and Rabies Vaccines Market Size by Country
  6. 7.2.1 North America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inactivated Polio and Rabies Vaccines Sales by Country
  2. 8.1.1 Europe Inactivated Polio and Rabies Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inactivated Polio and Rabies Vaccines Market Size by Country
  6. 8.2.1 Europe Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inactivated Polio and Rabies Vaccines Sales by Country
  2. 10.1.1 South America Inactivated Polio and Rabies Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inactivated Polio and Rabies Vaccines Market Size by Country
  6. 10.2.1 South America Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inactivated Polio and Rabies Vaccines Value Chain Analysis
  2. 12.1.1 Inactivated Polio and Rabies Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inactivated Polio and Rabies Vaccines Production Mode & Process
  7. 12.2 Inactivated Polio and Rabies Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inactivated Polio and Rabies Vaccines Distributors
  10. 12.2.3 Inactivated Polio and Rabies Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst